{"id":316134,"date":"2026-02-11T11:44:28","date_gmt":"2026-02-11T10:44:28","guid":{"rendered":"https:\/\/greenowl.fr\/blog\/?p=316134"},"modified":"2026-03-10T16:03:17","modified_gmt":"2026-03-10T15:03:17","slug":"novel-food","status":"publish","type":"post","link":"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/","title":{"rendered":"\u201cNovel Food\u201d et cannabidiol, ce qu\u2019il faut savoir en 2026"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_63 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<p class=\"ez-toc-title\">Sommaire<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-69d66ac358d88\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #336449;color:#336449\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #336449;color:#336449\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-69d66ac358d88\" checked aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Le_CBD_une_molecule_sous_surveillance\" title=\"Le\u00a0CBD, une mol\u00e9cule sous surveillance\u00a0\">Le\u00a0CBD, une mol\u00e9cule sous surveillance\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Quest-ce_quun_%E2%80%9CNovel_Food%E2%80%9D\" title=\"Qu\u2019est-ce qu\u2019un \u201cNovel Food\u201d ?\u00a0\">Qu\u2019est-ce qu\u2019un \u201cNovel Food\u201d ?\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Le_CBD_classe_comme_Novel_Food\" title=\"Le CBD class\u00e9 comme Novel Food\u00a0\">Le CBD class\u00e9 comme Novel Food\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Pas_dautorisation_Novel_Food_pour_le_CBD_a_ce_jour\" title=\"Pas d\u2019autorisation Novel Food pour le CBD \u00e0 ce jour\u00a0\">Pas d\u2019autorisation Novel Food pour le CBD \u00e0 ce jour\u00a0<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Preoccupations_sur_les_risques_hepatiques\" title=\"Pr\u00e9occupations sur les risques h\u00e9patiques\u00a0\">Pr\u00e9occupations sur les risques h\u00e9patiques\u00a0<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Une_dose_provisoire_fixee_par_lEFSA_en_decembre_2025\" title=\"Une dose provisoire fix\u00e9e par l&#8217;EFSA en d\u00e9cembre 2025\u00a0\">Une dose provisoire fix\u00e9e par l&#8217;EFSA en d\u00e9cembre 2025\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Effets_endocriniens_observes_chez_lanimal\" title=\"Effets endocriniens observ\u00e9s chez l&#8217;animal\u00a0\">Effets endocriniens observ\u00e9s chez l&#8217;animal\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Larret_Kanavape_un_tournant%E2%80%A6_mais_pas_une_autorisation\" title=\"L\u2019arr\u00eat\u00a0Kanavape\u00a0: un tournant\u2026 mais pas une autorisation\u00a0\">L\u2019arr\u00eat\u00a0Kanavape\u00a0: un tournant\u2026 mais pas une autorisation\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Quelle_est_la_situation_en_France%E2%80%AF\" title=\"Quelle est la situation en France\u202f?\u00a0\">Quelle est la situation en France\u202f?\u00a0<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Les_produits_a_ingerer_sont_interdits_sans_autorisation_Novel_Food\" title=\"Les produits \u00e0 ing\u00e9rer\u00a0sont\u00a0interdits sans autorisation Novel Food\u00a0\">Les produits \u00e0 ing\u00e9rer\u00a0sont\u00a0interdits sans autorisation Novel Food\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Le_seuil_de_THC_ne_doit_pas_depasser_03\" title=\"Le seuil de THC\u00a0ne doit pas d\u00e9passer\u00a00,3 %\u00a0\">Le seuil de THC\u00a0ne doit pas d\u00e9passer\u00a00,3 %\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Les_signaux_de_lANSES_vigilance_toxicologique\" title=\"Les signaux de l\u2019ANSES : vigilance toxicologique\u00a0\">Les signaux de l\u2019ANSES : vigilance toxicologique\u00a0<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Le_cas_britannique_une_regulation_plus_pragmatique\" title=\"Le cas britannique : une r\u00e9gulation plus pragmatique\u00a0\">Le cas britannique : une r\u00e9gulation plus pragmatique\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Quelles_sont_les_obligations_reglementaires_pour_la_commercialisation_du_CBD_dans_lUE\" title=\"Quelles sont les obligations r\u00e9glementaires pour la commercialisation du CBD dans l&#8217;UE\u00a0?\u00a0\">Quelles sont les obligations r\u00e9glementaires pour la commercialisation du CBD dans l&#8217;UE\u00a0?\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Quels_sont_les_risques_pour_les_consommateurs\" title=\"Quels sont les risques pour les consommateurs ?\u00a0\">Quels sont les risques pour les consommateurs ?\u00a0<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Des_produits_non_conformes\" title=\"Des produits non conformes\u00a0\">Des produits non conformes\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Des_donnees_toxicologiques_incompletes\" title=\"Des donn\u00e9es toxicologiques incompl\u00e8tes\u00a0\">Des donn\u00e9es toxicologiques incompl\u00e8tes\u00a0<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Quelles_sont_les_perspectives\" title=\"Quelles sont les perspectives ?\u00a0\">Quelles sont les perspectives ?\u00a0<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/novel-food\/#Sources\" title=\"Sources\u00a0\">Sources\u00a0<\/a><\/li><\/ul><\/nav><\/div>\n<p aria-level=\"4\"><i><span data-contrast=\"none\">R\u00e9sum\u00e9<\/span><\/i><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;134225954&quot;:true,&quot;134225961&quot;:true,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><i><span data-contrast=\"auto\">En 2026, le CBD est un Novel Food non autoris\u00e9 dans l\u2019UE. L\u2019EFSA a \u00e9tabli une dose provisoire de s\u00e9curit\u00e9 fix\u00e9e \u00e0 0,0275 mg\/kg de poids corporel par jour (soit environ 2 mg\/jour pour un adulte de 70 kg), applicable uniquement aux isolats de CBD \u2265 98 % de puret\u00e9.<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;134225954&quot;:true,&quot;134225961&quot;:true,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><i><span data-contrast=\"auto\">L\u2019EFSA juge les donn\u00e9es de s\u00e9curit\u00e9 insuffisantes, notamment sur le foie et la reproduction.<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;134225954&quot;:true,&quot;134225961&quot;:true,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><i><span data-contrast=\"auto\">En France, la DGCCRF poursuit ses contr\u00f4les et l\u2019ANSES alerte sur les risques toxicologiques.<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"5\" data-list-defn-props=\"{&quot;134225954&quot;:true,&quot;134225961&quot;:true,&quot;335552541&quot;:1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;multilevel&quot;}\" data-aria-posinset=\"4\" data-aria-level=\"1\"><i><span data-contrast=\"auto\">Le Royaume-Uni applique un r\u00e9gime transitoire plus pragmatique,\u00a0qui limite\u00a0les doses et\u00a0surveille\u00a0les produits list\u00e9s.<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2 aria-level=\"1\"><span class=\"ez-toc-section\" id=\"Le_CBD_une_molecule_sous_surveillance\"><\/span><span data-contrast=\"none\">Le\u00a0CBD, une mol\u00e9cule sous surveillance<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:240,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">En Europe, le march\u00e9 du CBD a d\u00e9pass\u00e9 2,6 milliards d&#8217;euros en 2024, selon le cabinet Prohibition\u00a0Partners. Environ 15 % des adultes europ\u00e9ens d\u00e9clarent avoir d\u00e9j\u00e0 consomm\u00e9 un produit contenant du\u00a0cannabidiol, principalement sous forme d&#8217;huile, de compl\u00e9ment alimentaire ou de boisson relaxante.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Le\u00a0cannabidiol, ou CBD, est l&#8217;un des plus de 100 cannabino\u00efdes identifi\u00e9s dans le chanvre. Contrairement au THC, il n&#8217;a pas d&#8217;effet psychotrope. Plusieurs \u00e9tudes pr\u00e9cliniques sugg\u00e8rent des effets potentiels sur la relaxation, le sommeil ou la gestion de la douleur, mais aucune all\u00e9gation de sant\u00e9 n&#8217;est aujourd&#8217;hui autoris\u00e9e par la Commission europ\u00e9enne.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Derri\u00e8re ce succ\u00e8s commercial se cache pourtant un cadre juridique strict. En Europe, les produits contenant du CBD destin\u00e9s \u00e0 \u00eatre ing\u00e9r\u00e9s (g\u00e9lules, huiles sublinguales, boissons, aliments) rel\u00e8vent du\u00a0<\/span><a href=\"https:\/\/eur-lex.europa.eu\/eli\/reg\/2015\/2283\/oj\/eng\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">r\u00e8glement (UE) 2015\/2283 sur les aliments nouveaux, appel\u00e9 \u201cNovel Food\u201d<\/span><\/a><span data-contrast=\"auto\">. [1]<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Quest-ce_quun_%E2%80%9CNovel_Food%E2%80%9D\"><\/span><span data-contrast=\"none\">Qu\u2019est-ce qu\u2019un \u201cNovel Food\u201d ?<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">Le r\u00e8glement (UE) 2015\/2283 d\u00e9finit comme \u00ab aliment nouveau \u00bb toute substance ou ingr\u00e9dient n&#8217;ayant pas \u00e9t\u00e9 consomm\u00e9 de mani\u00e8re significative avant mai 1997 dans l&#8217;Union europ\u00e9enne.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Avant toute mise sur le march\u00e9, un Novel Food doit obtenir une autorisation de la Commission europ\u00e9enne, fond\u00e9e sur une \u00e9valuation de s\u00e9curit\u00e9 r\u00e9alis\u00e9e par l&#8217;Autorit\u00e9 europ\u00e9enne de s\u00e9curit\u00e9 des aliments (EFSA).<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Cette proc\u00e9dure implique un dossier scientifique complet : donn\u00e9es toxicologiques, composition, stabilit\u00e9, exposition estim\u00e9e, interactions m\u00e9dicamenteuses, etc. L&#8217;objectif : garantir que le nouvel aliment est s\u00fbr pour la sant\u00e9 humaine.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Le_CBD_classe_comme_Novel_Food\"><\/span><span data-contrast=\"none\">Le CBD class\u00e9 comme Novel Food<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/food.ec.europa.eu\/food-safety\/novel-food\/novel-food-status-catalogue_en\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">Le Catalogue des Novel\u00a0Foods\u00a0de la Commission europ\u00e9enne indique<\/span><\/a><span data-contrast=\"auto\">\u00a0que\u00a0:<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><i><span data-contrast=\"auto\">\u201cLes extraits de Cannabis sativa L. et les produits d\u00e9riv\u00e9s contenant du cannabidiol (CBD) sont consid\u00e9r\u00e9s comme des aliments nouveaux, dans la mesure o\u00f9 l&#8217;historique de consommation de ces extraits n&#8217;a pas \u00e9t\u00e9 d\u00e9montr\u00e9 avant 1997.\u201d [6].<\/span><\/i><span data-ccp-props=\"{}\">\u00a0<\/span><span data-contrast=\"auto\">En d&#8217;autres termes, tous les produits alimentaires qui contiennent du CBD isol\u00e9, purifi\u00e9 ou extrait (compl\u00e9ments, boissons, confiseries, huiles ing\u00e9rables) sont soumis \u00e0 autorisation pr\u00e9alable avant leur commercialisation dans l&#8217;UE. Le seul cas non concern\u00e9 : les graines, farines ou huiles de chanvre traditionnelles, utilis\u00e9es depuis des si\u00e8cles et donc consid\u00e9r\u00e9es comme \u00ab non nouvelles \u00bb.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-316138 size-full aligncenter\" src=\"http:\/\/greenowl.fr\/blog\/wp-content\/uploads\/2026\/02\/cbd-catalogue-novel-food.png\" alt=\"catalogue novel food cbd\" width=\"1226\" height=\"605\" srcset=\"https:\/\/greenowl.fr\/blog\/wp-content\/uploads\/2026\/02\/cbd-catalogue-novel-food.png 1226w, https:\/\/greenowl.fr\/blog\/wp-content\/uploads\/2026\/02\/cbd-catalogue-novel-food-300x148.png 300w, https:\/\/greenowl.fr\/blog\/wp-content\/uploads\/2026\/02\/cbd-catalogue-novel-food-1024x505.png 1024w, https:\/\/greenowl.fr\/blog\/wp-content\/uploads\/2026\/02\/cbd-catalogue-novel-food-768x379.png 768w\" sizes=\"auto, (max-width: 1226px) 100vw, 1226px\" \/><\/p>\n<p style=\"text-align: center;\"><em><span class=\"TextRun SCXW155534300 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun ContextualSpellingAndGrammarErrorV2Themed SCXW155534300 BCX0\">Source\u202f:<\/span><span class=\"NormalTextRun SCXW155534300 BCX0\">\u00a0<\/span><span class=\"NormalTextRun SCXW155534300 BCX0\">https:\/\/food.ec.europa.eu\/food-safety\/novel-food\/consultation-process-novel-food-status_en<\/span><\/span><span class=\"EOP SCXW155534300 BCX0\" data-ccp-props=\"{&quot;335551550&quot;:2,&quot;335551620&quot;:2}\">\u00a0<\/span><\/em><\/p>\n<p>&nbsp;<\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Pas_dautorisation_Novel_Food_pour_le_CBD_a_ce_jour\"><\/span><span data-contrast=\"none\">Pas d\u2019autorisation Novel Food pour le CBD \u00e0 ce jour<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">Malgr\u00e9 plusieurs demandes d&#8217;autorisation d\u00e9pos\u00e9es depuis 2019, aucun produit \u00e0 base de CBD n&#8217;a encore obtenu de validation europ\u00e9enne au titre du r\u00e8glement (UE) 2015\/2283.\u00a0<\/span><a href=\"https:\/\/efsa.onlinelibrary.wiley.com\/doi\/10.2903\/j.efsa.2022.7322\" target=\"_blank\" rel=\"noopener\"><span data-contrast=\"none\">En 2022, l\u2019Autorit\u00e9 europ\u00e9enne de s\u00e9curit\u00e9 des aliments (EFSA) avait suspendu l\u2019examen des dossiers<\/span><\/a><span data-contrast=\"auto\">, estimant que les donn\u00e9es disponibles \u00e9taient insuffisantes pour \u00e9tablir la s\u00e9curit\u00e9 du\u00a0cannabidiol\u00a0comme aliment. Les principales pr\u00e9occupations concernaient :<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ul>\n<li><span data-contrast=\"auto\">Les effets sur le foie et le syst\u00e8me gastro-intestinal ;<\/span><\/li>\n<li><span data-contrast=\"auto\">Les impacts sur le syst\u00e8me nerveux et le comportement ;<\/span><\/li>\n<li><span data-contrast=\"auto\">Les\u00a0risques potentiels\u00a0pour la reproduction et le d\u00e9veloppement ;<\/span><\/li>\n<li><span data-contrast=\"auto\">Les interactions m\u00e9dicamenteuses, notamment via les enzymes h\u00e9patiques (CYP450) ;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"auto\">Les incertitudes relatives \u00e0 l\u2019exposition chronique et aux effets \u00e0 long terme.\u00a0<\/span><span data-contrast=\"auto\">[2].<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Depuis, de nouvelles donn\u00e9es ont \u00e9t\u00e9 examin\u00e9es par l&#8217;EFSA. En 2026, plus de 200 demandes d&#8217;autorisation avaient \u00e9t\u00e9 soumises \u00e0 la Commission europ\u00e9enne, dont 17 dossiers en cours d&#8217;\u00e9valuation scientifique par l&#8217;EFSA.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h3 aria-level=\"3\"><span class=\"ez-toc-section\" id=\"Preoccupations_sur_les_risques_hepatiques\"><\/span><span data-contrast=\"none\">Pr\u00e9occupations sur les risques h\u00e9patiques<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span data-contrast=\"auto\">Malgr\u00e9 la fixation d&#8217;une dose provisoire en d\u00e9cembre 2025, l&#8217;EFSA consid\u00e8re que la s\u00e9curit\u00e9 du CBD ne peut toujours pas \u00eatre \u00e9tablie, en particulier en raison du signal h\u00e9patique observ\u00e9 dans les \u00e9tudes r\u00e9centes.\u00a0<\/span><span data-contrast=\"auto\">Une \u00e9tude men\u00e9e en 2025 chez 201 adultes sains recevant environ 5 mg\/kg\/jour de CBD (\u2248 300\u2013400 mg\/jour) pendant 28 jours a montr\u00e9 :<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<ol>\n<li aria-setsize=\"-1\" data-leveltext=\"%1.\" data-font=\"Calibri\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:0,&quot;335559683&quot;:0,&quot;335559684&quot;:-1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769242&quot;:[65533,0,46],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;%1.&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">des\u00a0\u00e9l\u00e9vations d&#8217;ALT ou AST &gt; 3\u00d7 la limite sup\u00e9rieure de la normale chez 5 \u00e0 7 % des participants ;<\/span><\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"%1.\" data-font=\"Calibri\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:0,&quot;335559683&quot;:0,&quot;335559684&quot;:-1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769242&quot;:[65533,0,46],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;%1.&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">plusieurs\u00a0cas r\u00e9pondant aux crit\u00e8res de l\u00e9sion h\u00e9patique m\u00e9dicamenteuse (DILI) ;<\/span><\/li>\n<li aria-setsize=\"-1\" data-leveltext=\"%1.\" data-font=\"Calibri\" data-listid=\"11\" data-list-defn-props=\"{&quot;335552541&quot;:0,&quot;335559683&quot;:0,&quot;335559684&quot;:-1,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769242&quot;:[65533,0,46],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;%1.&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">une\u00a0\u00e9osinophilie associ\u00e9e, compatible avec un m\u00e9canisme immunologique.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ol>\n<p><span data-contrast=\"auto\">Les anomalies sont apparues apr\u00e8s environ trois semaines et ont r\u00e9gress\u00e9 \u00e0 l&#8217;arr\u00eat du traitement. La dur\u00e9e limit\u00e9e de l&#8217;\u00e9tude ne permet pas d&#8217;exclure un risque en cas d&#8217;exposition prolong\u00e9e.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">Un risque major\u00e9 d&#8217;\u00e9l\u00e9vation des enzymes h\u00e9patiques est \u00e9galement document\u00e9 en cas d&#8217;association avec certains m\u00e9dicaments, notamment le valproate et d&#8217;autres anti\u00e9pileptiques. Des incertitudes persistent par ailleurs concernant\u00a0<\/span><a href=\"https:\/\/greenowl.fr\/interaction-medicamenteuse-cbd\/\"><span data-contrast=\"none\">les effets endocriniens, reproductifs et les interactions m\u00e9dicamenteuses.<\/span><\/a><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Une_dose_provisoire_fixee_par_lEFSA_en_decembre_2025\"><\/span><span data-contrast=\"none\">Une dose provisoire fix\u00e9e par l&#8217;EFSA en d\u00e9cembre 2025<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">En d\u00e9cembre 2025, l&#8217;EFSA a r\u00e9alis\u00e9 une mod\u00e9lisation toxicologique (Benchmark Dose) \u00e0 partir d&#8217;\u00e9tudes\u00a0subchroniques\u00a0conformes aux Bonnes Pratiques de Laboratoire. En appliquant un facteur d&#8217;incertitude de 400, elle a fix\u00e9 une dose provisoirement s\u00fbre \u00e0 0,0275 mg\/kg\/jour. Cette valeur correspond \u00e0 environ 2 mg\/jour pour un adulte de 70 kg.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Cette dose ne concerne que les isolats de CBD d&#8217;une puret\u00e9 \u2265 98 %, sans nanoparticules, et produits selon un proc\u00e9d\u00e9 s\u00e9curis\u00e9 excluant toute g\u00e9notoxicit\u00e9.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Effets_endocriniens_observes_chez_lanimal\"><\/span><span data-contrast=\"none\">Effets endocriniens observ\u00e9s chez l&#8217;animal<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">Les \u00e9valuations r\u00e9centes de l&#8217;EFSA mettent en \u00e9vidence des effets endocriniens dans les \u00e9tudes animales. Une diminution des concentrations de thyroxine (T4) a \u00e9t\u00e9 observ\u00e9e d\u00e8s 30 mg\/kg\/jour, avec des effets statistiquement significatifs \u00e0 partir de 100 mg\/kg\/jour. Ces modifications s&#8217;accompagnaient, dans certaines \u00e9tudes, d&#8217;une hypertrophie des cellules folliculaires de la thyro\u00efde.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Des augmentations du poids des glandes surr\u00e9nales et des modifications histopathologiques ont \u00e9galement \u00e9t\u00e9 rapport\u00e9es, de mani\u00e8re dose-d\u00e9pendante, chez le rat.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">\u00c0 ce stade, les donn\u00e9es humaines sont insuffisantes pour d\u00e9terminer la pertinence clinique de ces observations, mais l&#8217;EFSA consid\u00e8re que ces \u00e9l\u00e9ments contribuent aux incertitudes persistantes sur la s\u00e9curit\u00e9 du CBD comme aliment.\u00a0<\/span><span data-contrast=\"auto\">[4].<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Larret_Kanavape_un_tournant%E2%80%A6_mais_pas_une_autorisation\"><\/span><span data-contrast=\"none\">L\u2019arr\u00eat\u00a0Kanavape\u00a0: un tournant\u2026 mais pas une autorisation<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\"><a href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/arret-kanavape\/\">Certains invoquent encore la c\u00e9l\u00e8bre affaire \u00ab\u00a0Kanavape\u00a0\u00bb<\/a>, jug\u00e9e par la Cour de justice de l&#8217;Union europ\u00e9enne (CJUE) en novembre 2020. [7]<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La Cour y a affirm\u00e9 que le CBD extrait de l&#8217;ensemble de la plante de chanvre, non stup\u00e9fiant, ne peut pas \u00eatre interdit \u00e0 la commercialisation entre \u00c9tats membres au titre de la libre circulation des marchandises, sauf motif de sant\u00e9 publique justifi\u00e9. Cependant, il faut bien comprendre que cet arr\u00eat ne cr\u00e9e pas d&#8217;autorisation alimentaire. Il clarifie uniquement que le CBD n&#8217;est pas un stup\u00e9fiant au sens du droit europ\u00e9en et qu&#8217;il ne peut \u00eatre discrimin\u00e9 commercialement. Autrement dit : la libre circulation reste conditionn\u00e9e au respect du droit alimentaire, dont le r\u00e8glement Novel Food.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Quelle_est_la_situation_en_France%E2%80%AF\"><\/span><span data-contrast=\"none\">Quelle est la situation en France\u202f?<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 aria-level=\"3\"><span class=\"ez-toc-section\" id=\"Les_produits_a_ingerer_sont_interdits_sans_autorisation_Novel_Food\"><\/span><span data-contrast=\"none\">Les produits \u00e0 ing\u00e9rer\u00a0sont\u00a0interdits sans autorisation Novel Food<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span data-contrast=\"auto\">En France, la DGCCRF consid\u00e8re toujours que les produits contenant du CBD destin\u00e9s \u00e0 \u00eatre ing\u00e9r\u00e9s (compl\u00e9ments, boissons, aliments) ne peuvent pas \u00eatre commercialis\u00e9s tant qu&#8217;ils ne disposent pas d&#8217;une autorisation Novel Food valide au niveau europ\u00e9en.\u00a0[3].<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">M\u00eame si certaines entreprises invoquent un \u00ab cadre transitoire \u00bb ou des d\u00e9p\u00f4ts de dossiers aupr\u00e8s de l&#8217;EFSA, cela ne constitue pas une autorisation. La DGCCRF conserve la possibilit\u00e9 de suspendre la vente, de saisir ou de sanctionner les op\u00e9rateurs non conformes.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h3 aria-level=\"3\"><span class=\"ez-toc-section\" id=\"Le_seuil_de_THC_ne_doit_pas_depasser_03\"><\/span><span data-contrast=\"none\">Le seuil de THC\u00a0ne doit pas d\u00e9passer\u00a00,3 %<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span data-contrast=\"auto\">Depuis le d\u00e9cret de 2023, la France a harmonis\u00e9 son seuil de THC \u00e0 0,3 % dans les vari\u00e9t\u00e9s de chanvre autoris\u00e9es, en coh\u00e9rence avec le droit europ\u00e9en. Ce seuil ne change toutefois rien \u00e0 la question du CBD alimentaire : un produit peut \u00eatre sans THC, mais rester ill\u00e9gal s&#8217;il n&#8217;a pas d&#8217;autorisation Novel Food.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h3 aria-level=\"3\"><span class=\"ez-toc-section\" id=\"Les_signaux_de_lANSES_vigilance_toxicologique\"><\/span><span data-contrast=\"none\">Les signaux de l\u2019ANSES : vigilance toxicologique<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span data-contrast=\"auto\">En parall\u00e8le, l\u2019Agence nationale de s\u00e9curit\u00e9 sanitaire (ANSES) a publi\u00e9 plusieurs avis appelant \u00e0 la prudence.\u00a0En 2023,\u00a0<\/span><a href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/cbd-presumee-toxique-reproduction\/\"><span data-contrast=\"none\">elle a propos\u00e9 de classer le CBD comme \u201cpr\u00e9sum\u00e9 toxique pour la reproduction \u2013 cat\u00e9gorie 1B\u201d selon le r\u00e8glement europ\u00e9en CLP<\/span><\/a><span data-contrast=\"auto\">.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Cette position, encore en d\u00e9bat au niveau europ\u00e9en, pourrait conduire \u00e0 de nouvelles restrictions pour les femmes enceintes, allaitantes ou sous traitement m\u00e9dicamenteux.\u00a0<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Les donn\u00e9es examin\u00e9es r\u00e9cemment par l\u2019EFSA confirment ces pr\u00e9occupations. Les \u00e9tudes animales mettent en \u00e9vidence des effets sur la fertilit\u00e9 et le d\u00e9veloppement : alt\u00e9ration de la spermatogen\u00e8se d\u00e8s 15 mg\/kg\/jour chez la souris, modifications des organes reproducteurs chez le rat et effets neurod\u00e9veloppementaux apr\u00e8s exposition pr\u00e9natale. Le passage transplacentaire du CBD a \u00e9galement \u00e9t\u00e9 d\u00e9montr\u00e9 dans les mod\u00e8les animaux. Sur cette base, l\u2019EFSA indique que la s\u00e9curit\u00e9 du CBD ne peut \u00eatre \u00e9tablie pour les personnes de moins de 25 ans, ni pour les femmes enceintes ou allaitantes.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Le_cas_britannique_une_regulation_plus_pragmatique\"><\/span><span data-contrast=\"none\">Le cas britannique : une r\u00e9gulation plus pragmatique<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">Depuis le Brexit, le Royaume-Uni applique son propre r\u00e9gime Novel Food, g\u00e9r\u00e9 par la Food Standards Agency (FSA).\u00a0Les autorit\u00e9s britanniques ont adopt\u00e9 une approche plus souple mais encadr\u00e9e : les entreprises ayant d\u00e9pos\u00e9 un dossier complet avant mars 2021 peuvent maintenir leurs produits sur le march\u00e9 pendant l&#8217;examen. [5].<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La FSA a publi\u00e9 une \u00ab Public List \u00bb recensant ces produits tol\u00e9r\u00e9s. Toutefois, cette liste ne vaut pas autorisation d\u00e9finitive ; elle sert simplement \u00e0 encadrer temporairement le march\u00e9 tout en attendant les conclusions de s\u00e9curit\u00e9.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">En 2026, la FSA recommande toujours :<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"12\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">Une dose journali\u00e8re maximale de 10 mg de CBD pour les adultes ;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"12\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Un seuil de THC tr\u00e8s bas : 0,07 mg par jour maximum ;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"12\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">Une information claire au consommateur sur les\u00a0risques potentiels\u00a0(somnolence, interactions m\u00e9dicamenteuses, atteintes h\u00e9patiques).<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">\u00c0 titre de comparaison, la dose provisoire retenue par l&#8217;EFSA en d\u00e9cembre 2025 est plus basse que la recommandation britannique de 10 mg\/jour.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Quelles_sont_les_obligations_reglementaires_pour_la_commercialisation_du_CBD_dans_lUE\"><\/span><span data-contrast=\"none\">Quelles sont les obligations r\u00e9glementaires pour la commercialisation du CBD dans l&#8217;UE\u00a0?<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">Pour les entreprises qui souhaitent commercialiser du CBD dans l&#8217;Union europ\u00e9enne, plusieurs \u00e9tapes sont n\u00e9cessaires :<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li><strong>D\u00e9terminer la cat\u00e9gorie du produit\u00a0<\/strong><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Il faut d&#8217;abord identifier si le produit rel\u00e8ve bien du champ alimentaire (compl\u00e9ment, boisson, confiserie) ou cosm\u00e9tique, voire pharmaceutique. Les cosm\u00e9tiques au CBD rel\u00e8vent du r\u00e8glement (CE) 1223\/2009 et du catalogue\u00a0CosIng, un autre cadre juridique.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li><strong>Pr\u00e9parer un dossier Novel Food complet\u00a0<\/strong><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Le dossier doit d\u00e9montrer :<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"15\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">la\u00a0s\u00e9curit\u00e9 d&#8217;emploi du produit ;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"15\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">la\u00a0composition et la puret\u00e9 de l&#8217;extrait ;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"15\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">la\u00a0tra\u00e7abilit\u00e9 de la mati\u00e8re premi\u00e8re ;<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"15\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"4\" data-aria-level=\"1\"><span data-contrast=\"auto\">les\u00a0conditions d&#8217;utilisation et d&#8217;\u00e9tiquetage.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Cette proc\u00e9dure est lourde : les co\u00fbts d&#8217;analyse et d&#8217;expertise se chiffrent souvent en centaines de milliers d&#8217;euros, et la dur\u00e9e d&#8217;instruction d\u00e9passe 18 \u00e0 24 mois.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li><strong>Surveiller la conformit\u00e9 en THC et contaminants\u00a0<\/strong><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">M\u00eame en dehors du cadre Novel Food, les produits au CBD doivent respecter les exigences du r\u00e8glement (CE) 1881\/2006 sur les contaminants (pesticides, m\u00e9taux lourds, hydrocarbures aromatiques polycycliques) et le r\u00e8glement (UE) 1169\/2011 sur l&#8217;\u00e9tiquetage. La conformit\u00e9 du THC total (&lt; 0,3 %) doit \u00eatre prouv\u00e9e par des analyses en laboratoire.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li><strong>Attention aux revendications th\u00e9rapeutiques\u00a0<\/strong><\/li>\n<\/ul>\n<p><span data-contrast=\"auto\">Toute mention sugg\u00e9rant un effet m\u00e9dical (anti-inflammatoire, anxiolytique, antidouleur, etc.) expose le fabricant \u00e0 une requalification en m\u00e9dicament par les autorit\u00e9s sanitaires. Seules les indications autoris\u00e9es\u00a0<\/span><a href=\"https:\/\/greenowl.fr\/blog\/blog-cbd-legislation\/lepidiolex-medicament-cannabidiol\/\"><span data-contrast=\"none\">dans le cadre de m\u00e9dicaments \u00e0 base de cannabis (comme l&#8217;Epidyolex\u00ae) sont l\u00e9gales.<\/span><\/a><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Quels_sont_les_risques_pour_les_consommateurs\"><\/span><span data-contrast=\"none\">Quels sont les risques pour les consommateurs ?<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3 aria-level=\"3\"><span class=\"ez-toc-section\" id=\"Des_produits_non_conformes\"><\/span><span data-contrast=\"none\">Des produits non conformes<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span data-contrast=\"auto\">De nombreux produits vendus en ligne ou en boutique \u00ab bien-\u00eatre \u00bb affichent des teneurs en CBD inexactes et parfois des traces de THC sup\u00e9rieures aux limites l\u00e9gales. Certains contiennent aussi des r\u00e9sidus de solvants ou de m\u00e9taux lourds issus de proc\u00e9d\u00e9s d&#8217;extraction mal ma\u00eetris\u00e9s.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<h3 aria-level=\"3\"><span class=\"ez-toc-section\" id=\"Des_donnees_toxicologiques_incompletes\"><\/span><span data-contrast=\"none\">Des donn\u00e9es toxicologiques incompl\u00e8tes<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><span data-contrast=\"auto\">Les \u00e9tudes disponibles montrent que le CBD peut influencer certaines fonctions physiologiques : m\u00e9tabolisme h\u00e9patique, r\u00e9gulation hormonale, vigilance, interactions m\u00e9dicamenteuses.\u00a0\u00c0 fortes doses, il peut provoquer somnolence, troubles digestifs, \u00e9l\u00e9vation des enzymes h\u00e9patiques ou alt\u00e9rations de la fertilit\u00e9 chez l&#8217;animal.<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">C&#8217;est pourquoi les autorit\u00e9s sanitaires pr\u00e9conisent :<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"16\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">de limiter les doses (10 mg\/jour au Royaume-Uni, pr\u00e9caution similaire envisag\u00e9e dans l&#8217;UE)<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"16\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">d&#8217;\u00e9viter la consommation pendant la grossesse ou sous traitement m\u00e9dical<\/span><\/li>\n<\/ul>\n<ul>\n<li aria-setsize=\"-1\" data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"16\" data-list-defn-props=\"{&quot;335552541&quot;:1,&quot;335559683&quot;:0,&quot;335559684&quot;:-2,&quot;335559685&quot;:720,&quot;335559991&quot;:360,&quot;469769226&quot;:&quot;Symbol&quot;,&quot;469769242&quot;:[8226],&quot;469777803&quot;:&quot;left&quot;,&quot;469777804&quot;:&quot;\uf0b7&quot;,&quot;469777815&quot;:&quot;hybridMultilevel&quot;}\" data-aria-posinset=\"3\" data-aria-level=\"1\"><span data-contrast=\"auto\">de\u00a0choisir des produits analys\u00e9s par des laboratoires accr\u00e9dit\u00e9s.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Quelles_sont_les_perspectives\"><\/span><span data-contrast=\"none\">Quelles sont les perspectives ?<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><span data-contrast=\"auto\">En 2025, plusieurs acteurs europ\u00e9ens \u2014 producteurs, associations, instituts de recherche \u2014 travaillent \u00e0 fournir \u00e0 l&#8217;EFSA les donn\u00e9es manquantes sur la toxicologie du CBD.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Les discussions portent sur la mise en place d&#8217;un \u00ab cadre de tol\u00e9rance transitoire \u00bb : il s&#8217;agirait d&#8217;autoriser temporairement les produits dont la s\u00e9curit\u00e9 est jug\u00e9e plausible, tout en poursuivant la collecte de donn\u00e9es scientifiques.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Mais rien n&#8217;est encore d\u00e9cid\u00e9. La Commission europ\u00e9enne reste tr\u00e8s prudente, craignant d&#8217;autoriser un produit avant d&#8217;avoir \u00e9valu\u00e9 ses effets \u00e0 long terme.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><i><span data-contrast=\"auto\">Article r\u00e9dig\u00e9 sur la base des positions officielles de la Commission europ\u00e9enne, de l&#8217;EFSA, de la DGCCRF, de l&#8217;ANSES et de la FSA britannique (mise \u00e0 jour f\u00e9vrier 2026).<\/span><\/i><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2 aria-level=\"2\"><span class=\"ez-toc-section\" id=\"Sources\"><\/span><span data-contrast=\"none\">Sources<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><i><span data-contrast=\"auto\">[1]\u00a0\u00a0https:\/\/eur-lex.europa.eu\/eli\/reg\/2015\/2283\/oj<\/span><\/i><br \/>\n<i><span data-contrast=\"auto\">[2] https:\/\/www.efsa.europa.eu\/en\/topics\/topic\/cannabidiol<\/span><\/i><br \/>\n<i><span data-contrast=\"auto\">[3]\u00a0https:\/\/www.economie.gouv.fr\/dgccrf<\/span><\/i><br \/>\n<i><span data-contrast=\"auto\">[4] https:\/\/www.anses.fr\/fr\/content\/cbd-et-sante<\/span><\/i><br \/>\n<i><span data-contrast=\"auto\">[5]\u00a0https:\/\/www.food.gov.uk\/business-guidance\/cannabidiol-cbd<\/span><\/i><br \/>\n<i><span data-contrast=\"auto\">[6]\u00a0https:\/\/eur-lex.europa.eu<\/span><\/i><br \/>\n<i><span data-contrast=\"auto\">[7] https:\/\/food.ec.europa.eu\/food-safety\/novel-food\/novel-food-catalogue_en<\/span><\/i><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335551550&quot;:0,&quot;335551620&quot;:0,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-ccp-props=\"{}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>R\u00e9sum\u00e9\u00a0 En 2026, le CBD est un Novel Food non autoris\u00e9 dans l\u2019UE. L\u2019EFSA a \u00e9tabli une dose provisoire de s\u00e9curit\u00e9 fix\u00e9e \u00e0 0,0275 mg\/kg de poids corporel par jour (soit environ 2 mg\/jour pour un adulte de 70 kg), applicable uniquement aux isolats de CBD \u2265 98 % de puret\u00e9.\u00a0 L\u2019EFSA juge les donn\u00e9es<\/p>\n","protected":false},"author":2,"featured_media":316136,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-316134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-cbd-legislation"],"_links":{"self":[{"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/posts\/316134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/comments?post=316134"}],"version-history":[{"count":5,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/posts\/316134\/revisions"}],"predecessor-version":[{"id":316334,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/posts\/316134\/revisions\/316334"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/media\/316136"}],"wp:attachment":[{"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/media?parent=316134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/categories?post=316134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/greenowl.fr\/blog\/wp-json\/wp\/v2\/tags?post=316134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}